UNSPSC 51162338: Atropine/chlorpheniramine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162338 Atropine/chlorpheniramine is a Commodity code representing pharmaceutical products—specifically emergency medications and controlled substances—that state and local governments procure for healthcare delivery to incarcerated and community populations. The Washington State Department of Corrections and Seminole County, Florida are actively soliciting parenteral products including atropine-class compounds, naloxone, and related injectables through competitive bidding. State and local healthcare systems—including corrections departments and county health departments—are the primary issuing bodies under this code. These entities require reliable sourcing of controlled pharmaceutical compounds for emergency response, overdose reversal, and medical necessity in correctional settings and public health programs, with strict regulatory compliance, insurance requirements, and rapid fulfillment mandates.

The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, due October 7, 2026, seeking parenteral products and services for eight correctional facilities across the state, with anticipated awards to up to three bidders per region and a contract term running through June 30, 2030. Seminole County, Florida issued IFB 60459723LAS in June 2026 for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries required. Recent activity concentrates in Washington and Florida, with Washington prioritizing women-owned and minority-owned business participation through set-asides (6% WBE, 10% MBE, 5% VBE, and a 25% small business preference) and requiring documented experience in IV solution preparation, 24-hour delivery capability for specialty compounds, and comprehensive liability and cyber-liability insurance ($2 million aggregate coverage). Florida's procurement reflects public health overdose-response priorities with fixed-price contracting over two-year initial terms.